Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prophylactic Natural Killer Cell Immunotherapy Following HLA-Haploidentical Hematopoietic Cell Transplantation Prevents Relapse and Improves Survival in Patients with High-Risk Hematological Malignancies

Monica Thakar, MD, Parameswaran Hari, MD MRCP, MS, David G. Maloney, MD PhD, Carolyn A. Keever-Taylor, PhD, Lori Jones, PhD, Shelly Heimfeld, PhD, Rainer F. Storb, MD, Brenda M. Sandmaier, MD

Blood (2016) 128 (22): 1161.

https://doi.org/10.1182/blood.V128.22.1161.1161

Published: 2016

Journal Articles

CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia

Cameron J Turtle, MBBS, PhD, Laila-Aicha Hanafi, PhD, Daniel Li, PhD, Colette Chaney, RN, Shelly Heimfeld, PhD, Stanley R Riddell, MD, David G Maloney, MD PhD

Blood (2016) 128 (22): 56.

https://doi.org/10.1182/blood.V128.22.56.56

Published: 2016

Journal Articles

Biomarkers of Cytokine Release Syndrome and Neurotoxicity after CD19 CAR-T Cells and Mitigation of Toxicity By Cell Dose

Cameron J Turtle, MBBS, PhD, Kevin A Hay, MDFRCPC, MSc, Gust Juliane, MD PhD, Laila-Aicha Hanafi, PhD, Daniel Li, PhD, Colette Chaney, RN, Shelly Heimfeld, PhD, Stanley R Riddell, MD, David G. Maloney, MD PhD

Blood (2016) 128 (22): 1852.

https://doi.org/10.1182/blood.V128.22.1852.1852

Published: 2016

Journal Articles

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Cameron J Turtle, MBBS, PhD, Laila-Aicha Hanafi, PhD, Carolina Berger, MD, Daniel Sommermeyer, PhD, Barbara Pender, MS, Emily M Robinson, BS, Katherine Melville, Tanya M Budiarto, BSc, Natalia N Steevens, Colette Chaney, RN, Sindhu Cherian, MD, Brent L Wood, MD PhD, Lorinda Soma, MD, Xueyan Chen, MD PhD, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R. Riddell, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 3773.

https://doi.org/10.1182/blood.V126.23.3773.3773

Published: 2015

Journal Articles

A Point-of-Care Platform for Hematopoietic Stem Cell Gene Therapy

Jennifer E Adair, PhD, Kevin G Haworth, PhD, Guy Sauvageau, MD, PhD, Shelly Heimfeld, PhD, Jonah D Hocum, B.S., Grant D. Trobridge, PhD, Hans-Peter Kiem, MD

Blood (2015) 126 (23): 4416.

https://doi.org/10.1182/blood.V126.23.4416.4416

Published: 2015

Journal Articles

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Cameron J Turtle, MBBS, PhD, Carolina Berger, MD, Daniel Sommermeyer, PhD, Laila-Aicha Hanafi, PhD, Barbara Pender, MS, Emily M Robinson, BS, Katherine Melville, Tanya M Budiarto, BSc, Natalia N Steevens, Colette Chaney, RN, Sindhu Cherian, MD, Brent L Wood, MD PhD, Lorinda Soma, MD, Xueyan Chen, MD PhD, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R. Riddell, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 184.

https://doi.org/10.1182/blood.V126.23.184.184

Published: 2015

Journal Articles

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Merav Bar, MD, Aude G. Chapuis, MD, Thomas M Schmitt, PhD, Hieu Nguyen, Natalie A Duerkopp, Mark F Tom, Felecia D Wagener, Colette N Chaney, RN, Kieu-Thu Bui, RN, Shelly Heimfeld, PhD, Philip D. Greenberg, MD

Blood (2014) 124 (21): 3939.

https://doi.org/10.1182/blood.V124.21.3939.3939

Published: 2014

Journal Articles

Real-Time Immunophenotyping of Peripheral Blood Early Post Myeloablative Cord Blood Transplant Can Identify Patients at Risk for Primary Graft Failure

Jianqiang Li, PhD, Filippo Milano, MD PhD, Joseph M Blake, David C. Oliver, Ian Nicoud, PhD, Shelly Heimfeld, PhD, Colleen Delaney, MD

Blood (2014) 124 (21): 3897.

https://doi.org/10.1182/blood.V124.21.3897.3897

Published: 2014

Journal Articles

Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition

Cameron J Turtle, MBBS, PhD, Daniel Sommermeyer, PhD, Carolina Berger, MD, Michael Hudecek, MD, David M Shank, Natalia N Steevens, BS, Tanya M Budiarto, BSc, Mandana Karimi, MS, Colette N Chaney, RN, Anna Marie DeVito, RN, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R Riddell, MD, David G Maloney, MDPhD

Blood (2014) 124 (21): 384.

https://doi.org/10.1182/blood.V124.21.384.384

Published: 2014

Journal Articles

Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

Filippo Milano, MD PhD, Shelly Heimfeld, PhD, Ivy B. Riffkin, Ian Nicoud, PhD, Frederick R. Appelbaum, MD, Irwin D. Bernstein, MD, Colleen Delaney, MD

Blood (2014) 124 (21): 46.

https://doi.org/10.1182/blood.V124.21.46.46

Published: 2014

Journal Articles

Notch-Expanded Murine Hematopoietic Progenitor Cells Can Induce Immune Tolerance in Mismatched Recipients

Fabiola V Merriam, PhD, Ian Nicoud, PhD, Filippo Milano, MD PhD, Jianqiang Li, PhD, Shelly Heimfeld, PhD, Colleen Delaney, MD

Blood (2014) 124 (21): 2430.

https://doi.org/10.1182/blood.V124.21.2430.2430

Published: 2014

Journal Articles

Dose Dependent Enhancement Of Neutrophil Recovery By Infusion Of Notch Ligand Ex Vivo Expanded Cord Blood Progenitors: Results Of a Multi-Center Phase I Trial

Colleen Delaney, MD, MSC, Filippo Milano, MD, PhD, Ian Nicoud, PhD, Shelly Heimfeld, PhD, Chatchada Karanes, MD, Jonathan A Gutman, MD, John E. Wagner, MD, Frederick R. Appelbaum, MD, Irwin D. Bernstein, MD

Blood (2013) 122 (21): 297.

https://doi.org/10.1182/blood.V122.21.297.297

Published: 2013

Journal Articles

Infusion of “off-the-shelf” Third Party Ex Vivo Expanded Cord Blood Progenitor Cells As Supportive Care Following Clofarabine with High Dose Cytarabine and Granulocyte Colony-Stimulating Factor Priming for the Treatment of AML,

Colleen Delaney, MD, Pamela S Becker, MD, PhD, Filippo Milano, MD, PhD, Ian Nicoud, PhD, Shelly Heimfeld, PhD, Ivy Riffkin, Adrienne Papermaster, Frederick R. Appelbaum, MD, Irwin D. Bernstein, MD, Elihu H. Estey, MD

Blood (2011) 118 (21): 3640.

https://doi.org/10.1182/blood.V118.21.3640.3640

Published: 2011

Journal Articles

Influence of Infused Naïve CD3 + CD8 + and CD3 + CD56 + NKT-Cells on Single Unit Dominance After Double Cord Blood Transplantation

Filippo Milano, MD, PhD, Shelly Heimfeld, PhD, Ted Gooley, Ian Nicoud, PhD, Colleen Delaney

Blood (2011) 118 (21): 652.

https://doi.org/10.1182/blood.V118.21.652.652

Published: 2011

Journal Articles

Infusion of Mismatched Ex Vivo Expanded and Cryopreserved Murine Hematopoietic Progenitors Rescues Mice After Lethal Radiation Exposure,

Filippo Milano, MD, PhD, Ian Nicoud, PhD, Daniel Weber, Irwin D. Bernstein, MD, Shelly Heimfeld, PhD, Colleen Delaney, MD

Blood (2011) 118 (21): 4006.

https://doi.org/10.1182/blood.V118.21.4006.4006

Published: 2011

Journal Articles

Cryopreserved Ex-Vivo Expanded Murine Hematopoietic Progenitors Can Engraft Across MHC Barriers and Improve Survival In a Murine Model of Acute Radiation Syndrome.

Filippo Milano, MD, PhD, Ian Nicoud, PhD, Daniel Weber, Shelly Heimfeld, PhD, Irwin D. Bernstein, MD, Colleen Delaney

Blood (2010) 116 (21): 1463.

https://doi.org/10.1182/blood.V116.21.1463.1463

Published: 2010

Journal Articles

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

Shelly Heimfeld, PhD, Ted Gooley, Mary Flowers, MD, Frederic Baron, MD, PhD, Paul J. Martin, MD, Michael L. Linenberger, MD, Rainer F. Storb, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD

Blood (2010) 116 (21): 676.

https://doi.org/10.1182/blood.V116.21.676.676

Published: 2010

Journal Articles

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Olga Sala-Torra, MD, Holly M. Gundacker, Derek L. Stirewalt, MD, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, PhD, Cheryl L. Willman, MD, Shelly Heimfeld, PhD, David H. Boldt, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 336.

https://doi.org/10.1182/blood.V106.11.336.336

Published: 2005

NARROW

Prophylactic Natural Killer Cell Immunotherapy Following HLA-Haploidentical Hematopoietic Cell Transplantation Prevents Relapse and Improves Survival in Patients with High-Risk Hematological Malignancies

CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia

Biomarkers of Cytokine Release Syndrome and Neurotoxicity after CD19 CAR-T Cells and Mitigation of Toxicity By Cell Dose

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

A Point-of-Care Platform for Hematopoietic Stem Cell Gene Therapy

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Real-Time Immunophenotyping of Peripheral Blood Early Post Myeloablative Cord Blood Transplant Can Identify Patients at Risk for Primary Graft Failure

Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition

Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

Notch-Expanded Murine Hematopoietic Progenitor Cells Can Induce Immune Tolerance in Mismatched Recipients

Dose Dependent Enhancement Of Neutrophil Recovery By Infusion Of Notch Ligand Ex Vivo Expanded Cord Blood Progenitors: Results Of a Multi-Center Phase I Trial

Infusion of “off-the-shelf” Third Party Ex Vivo Expanded Cord Blood Progenitor Cells As Supportive Care Following Clofarabine with High Dose Cytarabine and Granulocyte Colony-Stimulating Factor Priming for the Treatment of AML,

Influence of Infused Naïve CD3 + CD8 + and CD3 + CD56 + NKT-Cells on Single Unit Dominance After Double Cord Blood Transplantation

Infusion of Mismatched Ex Vivo Expanded and Cryopreserved Murine Hematopoietic Progenitors Rescues Mice After Lethal Radiation Exposure,

Cryopreserved Ex-Vivo Expanded Murine Hematopoietic Progenitors Can Engraft Across MHC Barriers and Improve Survival In a Murine Model of Acute Radiation Syndrome.

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only